Evidence map›Paper›PMID 32758306›Full record

ReviewThe British journal of nutrition2021

Selenium and viral infection: are there lessons for COVID-19?

Giovanna Bermano, Catherine Méplan, Derry K Mercer, John E Hesketh

Open access · hybridAbstract readReview
In one paragraph

Review in The British journal of nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. COVID-19 and Selenium Deficiency: a Systematic Review.Biological trace element research · 2022
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. The protective effects of selenium against NLRP3-mediated inflammation and pyroptosis: mechanisms and the potential health benefits.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. The role of cell death in SARS-CoV-2 infection.Signal transduction and targeted therapy · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Giovanna Bermano *Centre for Obesity Research and Education (CORE), School of Pharmacy and Life Sciences, Robert Gordon University, AberdeenAB10 7GJ, UK.
Catherine Méplan *School of Biomedical, Nutritional and Sport Sciences, Faculty of Medical Sciences, Newcastle University, Newcastle upon TyneNE2 4HH, UK.
Derry K MercerCentre for Obesity Research and Education (CORE), School of Pharmacy and Life Sciences, Robert Gordon University, AberdeenAB10 7GJ, UK.
John E Hesketh *Centre for Obesity Research and Education (CORE), School of Pharmacy and Life Sciences, Robert Gordon University, AberdeenAB10 7GJ, UK.
Robert Gordon University · GBNewcastle University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Se is a micronutrient essential for human health. Sub-optimal Se status is common, occurring in a significant proportion of the population across the world including parts of Europe and China. Human and animal studies have shown that Se status is a key determinant of the host response to viral infections. In this review, we address the question whether Se intake is a factor in determining the severity of response to coronavirus disease 2019 (COVID-19). Emphasis is placed on epidemiological and animal studies which suggest that Se affects host response to RNA viruses and on the molecular mechanisms by which Se and selenoproteins modulate the inter-linked redox homeostasis, stress response and inflammatory response. Together these studies indicate that Se status is an important factor in determining the host response to viral infections. Therefore, we conclude that Se status is likely to influence human response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and that Se status is one (of several) risk factors which may impact on the outcome of SARS-CoV-2 infection, particularly in populations where Se intake is sub-optimal or low. We suggest the use of appropriate markers to assess the Se status of COVID-19 patients and possible supplementation may be beneficial in limiting the severity of symptoms, especially in countries where Se status is regarded as sub-optimal.

Indexed as

AnimalsCOVID-19HumansInflammationMicronutrientsNutritional StatusOxidation-ReductionRNA, ViralSARS-CoV-2SeleniumStress, PhysiologicalVirus DiseasesMicronutrientsRNA, ViralSeleniumCOVID-19InflammationMicronutrientsRedox statusSeleniumSevere acute respiratory syndrome coronavirus 2Viral infection

Identifiers

PMID32758306
PMCPMC7503044
OpenAlexW3043969370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.